Detection of local prostate cancer recurrence after EBRT

Data from a small study at the University of California at San Francisco suggest that magnetic resonance (MR) spectroscopic imaging is better than  T2-weighted MR imaging alone for the detection of locally recurrent prostate cancer after definitive external beam radiation therapy (EBRT) as first-line therapy. … READ MORE …